A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI [Protect II]
ID Number 08-0386Principal Investigator(s)
Samin K Sharma
Department(s) or Division(s)
The Zena and Michael A. Wiener Cardiovascular Institute
The purpose of the study is to assess the safety and efficacy of the Impella 2.5 system compared to intra-aortic balloon pump (IABP) use in participants undergoing non-emergent high-risk percutaneous coronary intervention (stent placement). The goal is to monitor the major adverse events like death, stroke and heart attack. The outcome will be compared to the control group treated with IABP.
Recruiting Patients: Yes